PTEN and endometrial cancer: Interestingly, loss of Apc alone did not drive malignant transformation in an endometrial cancer mouse model unless combined with concomitant Pten loss [27], thereby suggesting that not all WNT pathway mutations are equal in their transforming potential in endometrial cancer.